Skip to main content
SpringerLink
Log in

Medication Treatments

  • Chapter
  • First Online:
Fibromyalgia

  • 2068 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders. 2007;8:27.

    Article  PubMed  Google Scholar 

  2. Arnold LM, Hudson JI, Wang F, et al. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Clin J Pain. 2009;25:461–8.

    Article  PubMed  Google Scholar 

  3. Mainguy Y. Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran. Hum Psychopharmacol. 2009;24:S19–23.

    Article  PubMed  Google Scholar 

  4. Häuser W, Bernardy K, üçeyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA. 2009a;301:198–209.

    Article  PubMed  Google Scholar 

  5. Littlejohn GO, Guymer EK. Fibromyalgia syndrome: which antidepressant drug should we choose. Curr Pharm Des. 2006;12:3–9.

    Article  PubMed  CAS  Google Scholar 

  6. Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med. 2007;8:S63–74.

    Article  PubMed  Google Scholar 

  7. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974–84.

    Article  PubMed  CAS  Google Scholar 

  8. Mease PJ, Russell J, Kajdasz DK, et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010;39:454–64.

    Google Scholar 

  9. Chappell AS, Littlejohn G, Kajdasz DK, et al. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. Clin J Pain. 2009;25:365–75.

    Article  PubMed  Google Scholar 

  10. Hudson JI, Arnold LM, Bradley LA, et al. What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine. J Rheumatol. 2009;36:2517–22.

    Article  PubMed  Google Scholar 

  11. Farrar JT, Pritchett YL, Robinson M, Praakash A, Chappell A. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. J Pain. 2010;11:109–18.

    Article  PubMed  CAS  Google Scholar 

  12. Arnold LM, Pritchett YL, D-Souza DN, et al. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials. J Womens Health. 2007;16:1145–56.

    Article  Google Scholar 

  13. Choy EH, Mease PJ, Kajdasz DK, et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol. 2009;28:1035–44.

    Article  PubMed  Google Scholar 

  14. Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36:398–409.

    Article  PubMed  CAS  Google Scholar 

  15. Nishishinya B, Urrútia G, Walitt B, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology. 2008;47:1741–6.

    Article  PubMed  CAS  Google Scholar 

  16. Patkar AA, Masand PS, Krulewicz S, et al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med. 2007;120:448–54.

    Article  PubMed  CAS  Google Scholar 

  17. Arnold LM, Hess EV, Hudson JI, et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112:191–7.

    Article  PubMed  CAS  Google Scholar 

  18. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336–44.

    Article  PubMed  CAS  Google Scholar 

  19. http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm (Accessed February. 2008).

  20. Häuser W, Bernardy K, üçeyler N, Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin – a meta-analysis of randomized controlled trials. Pain. 2009b;145:69–81.

    Article  PubMed  Google Scholar 

  21. Cappelleri JC, Bushmakin AG, Zlateva G, Sadosky A. Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results. Pain Pract. 2009;9:348–53.

    Article  PubMed  Google Scholar 

  22. RussellIJ, Perkins AT, Michalek JE. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum. 2009;60:299–309.

    Article  Google Scholar 

  23. Mease PJ, Swick TJ, Alvarez-Horine S, et al. Sodium oxybate improves fatigue, sleep disturbance, and PGIC in fibromyalgia: results from a phase III, 14-week controlled trial. Presented at the 2009 ACR/ARHP Annual Scientific Meeting, October 16–21, 2009, Philadelphia, PA.

    Google Scholar 

  24. Wang YG, Swick TJ, Carter LP, Thorpy MJ, Benowitz NL. Safety overview of poatmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion. J Clin Sleep Med. 2009;5:365–71.

    PubMed  CAS  Google Scholar 

  25. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114:537–45.

    Article  PubMed  CAS  Google Scholar 

  26. Bennett RM, Schein J, Kosinski MR, et al. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum. 2005;53:519–27.

    Article  PubMed  Google Scholar 

  27. Kim SH, Song J, Mun H, Park KU. Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia. Korean J Intern Med. 2009;24:139–42.

    Article  PubMed  CAS  Google Scholar 

  28. Häuser W, Arnold B, Eich W, et al. Management of fibromylagia syndrome – an interdisciplinary evidence-based guideline. Ger Med Soc. 2008;6:doc 14.

    Google Scholar 

  29. Lautenschläger J. Present state of medication therapy in fibromyalgia syndrome. Scand J Rheumatol. 2000;29:32–6.

    Article  Google Scholar 

  30. Krenzelok EP. The FDA acetaminophen advisory committee meeting – what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol (Phila). 2009;47:784–9.

    Article  CAS  Google Scholar 

  31. Russell IJ, Mease PJ, Smith TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136:432–44.

    Article  PubMed  CAS  Google Scholar 

  32. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology. 2008;8:29.

    Article  PubMed  Google Scholar 

  33. Krell HV, Leuchter AF, Cook IA, Abrams M. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics. 2005;46:379–84.

    Article  PubMed  CAS  Google Scholar 

  34. Schwartz TL, Rayancha S, Rashid A, et al. Modafinil treatment for fatigue associated with fibromyalgia. J Clin Rheumatol. 2007;13:52.

    Article  PubMed  Google Scholar 

  35. Hidalgo J, Rico-Villademoros F, Calandre EP. An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:71–7.

    Article  PubMed  CAS  Google Scholar 

  36. Toda K, Tobimatsu Y. Effiacy of neurotropin in fibromyalgia: a case report. Pain Med. 2008;9:460–3.

    Article  PubMed  Google Scholar 

  37. Cuatrecasas G, Riudavets C, Güell MA, Nadal A. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study. BMC Musculoskelet Disord. 2007;8:119.

    Article  PubMed  Google Scholar 

  38. Schafranski MD, Malucelli T, Machado F, et al. Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clin Rheumatol. 2009;28:853–5.

    Article  PubMed  Google Scholar 

  39. Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine. 2008;75:397–402.

    Article  PubMed  Google Scholar 

  40. Toda K, Kimura H. Efficacy of neurotropin in chronic fatigue syndrome: a case report. Efficacy of neurotropin in chronic fatigue syndrome: a case report. Hiroshima J Med Sci. 2006;55:35–7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh, 3550 Terrace St., A-1305 Scaife Hall, Pittsburgh, Pennsylvania, 15261, USA

    Dawn A. Marcus

  2. Division of Arthritis & Rheumatic Diseases (OP09), Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA

    Atul Deodhar MD

Authors
  1. Dawn A. Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atul Deodhar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dawn A. Marcus .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Marcus, D.A., Deodhar, A. (2011). Medication Treatments. In: Fibromyalgia. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1609-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1609-9_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1608-2

  • Online ISBN: 978-1-4419-1609-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation